Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina

2022 /PRNewswire/ — Shanghai ZhenGe Biotech Co., Ltd. (“ZhenGe Biotech” or “the Company”) announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management …
( read original story …)

---